Effect of subchronic phencyclidine administration on sucrose preference and hippocampal parvalbumin immunoreactivity in the rat

Neuroscience Letters

Volumn 471, Issue 3, 2010, Pages 144-147

  Jenkins, Trisha A ^a,c   Harte, Michael K ^b   Reynolds, Gavin P ^c  

^a RMIT UNIVERSITY   (Australia)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Anhedonia; Drinking; Hippocampus; Parvalbumin; Phencyclidine; Rat

Indexed keywords

PARVALBUMIN; PHENCYCLIDINE; SUCROSE; WATER;

ANHEDONIA; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; FLUID INTAKE; HIPPOCAMPUS; IMMUNOREACTIVITY; MALE; NEGATIVE SYNDROME; NERVE CELL; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS INHIBITION; RAT; SUGAR INTAKE; TASTE PREFERENCE;

AFFECTIVE SYMPTOMS; ANIMALS; CHOICE BEHAVIOR; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING BEHAVIOR; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; NEURONS; PARVALBUMINS; PHENCYCLIDINE; PLEASURE; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SUCROSE; TASTE;

EID: 76749151747     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.01.028     Document Type: Article

References (46)

1. Abdul-Monim Z., Neill J.C., and Reynolds G.P. Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat. Journal of Psychopharmacology (Oxford, England) 21 (2007) 198-205
2. Abdul-Monim Z., Reynolds G.P., and Neill J.C. The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat. Journal of Psychopharmacology (Oxford, England) 17 (2003) 57-65
3. Adams B., and Moghaddam B. Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 18 (1998) 5545-5554
4. Allaman I., Papp M., Kraftsik R., Fiumelli H., Magistretti P.J., and Martin J.L. Expression of brain-derived neurotrophic factor is not modulated by chronic mild stress in the rat hippocampus and amygdala. Pharmacological Reports: PR 60 (2008) 1001-1007
5. Baird J.P., Turgeon S., Wallman A., and Hulick V. Behavioral processes mediating phencyclidine-induced decreases in voluntary sucrose consumption. Pharmacology, Biochemistry and Behavior 88 (2008) 272-279
6. Brown T.S., and Murphy H.M. Factors affecting sucrose preference behavior in rats with hippocampal lesions. Physiology & Behavior 11 (1973) 833-844
7. Castellani S., and Adams P.M. Acute and chronic phencyclidine effects on locomotor activity, stereotypy and ataxia in rats. European Journal of Pharmacology 73 (1981) 143-154
8. Ellenbroek B.A., and Cools A.R. Animal models for the negative symptoms of schizophrenia. Behavioural Pharmacology 11 (2000) 223-233
9. Frederick D.L., Gillam M.P., Allen R.R., and Paule M.G. Acute behavioral effects of phencyclidine on rhesus monkey performance in an operant test battery. Pharmacology, Biochemistry, and Behavior 52 (1995) 789-797
10. Geyer M.A., Segal D.S., and Greenberg B.D. Increased startle responding in rats treated with phencyclidine. Neurobehavioral Toxicology and Teratology 6 (1984) 161-164
11. Grayson B., Idris N.F., and Neill J.C. Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat. Behavioural Brain Research 184 (2007) 31-38
12. Grippo A.J., Beltz T.G., and Johnson A.K. Behavioral and cardiovascular changes in the chronic mild stress model of depression. Physiology & Behavior 78 (2003) 703-710
13. Grippo A.J., Francis J., Beltz T.G., Felder R.B., and Johnson A.K. Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia. Physiology & Behavior 84 (2005) 697-706
14. Grippo A.J., Sullivan N.R., Damjanoska K.J., Crane J.W., Carrasco G.A., Shi J., Chen Z., Garcia F., Muma N.A., and Van de Kar L.D. Chronic mild stress induces behavioral and physiological changes, and may alter serotonin 1A receptor function, in male and cycling female rats. Psychopharmacology 179 (2005) 769-780
15. Gronli J., Fiske E., Murison R., Bjorvatn B., Sorensen E., Ursin R., and Portas C.M. Extracellular levels of serotonin and GABA in the hippocampus after chronic mild stress in rats. A microdialysis study in an animal model of depression. Behavioural Brain Research 181 (2007) 42-51
16. Jenkins T.A., Harte M.K., McKibben C.E., Elliott J.J., and Reynolds G.P. Disturbances in social interaction occur along with pathophysiological deficits following sub-chronic phencyclidine administration in the rat. Behavioural Brain Research 194 (2008) 230-235
17. Jentsch J.D., and Roth R.H. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 20 (1999) 201-225
18. Jentsch J.D., Taylor J.R., and Roth R.H. Subchronic phencyclidine administration increases mesolimbic dopaminergic system responsivity and augments stress- and psychostimulant-induced hyperlocomotion. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 19 (1998) 105-113
19. Jentsch J.D., Tran A., Le D., Youngren K.D., and Roth R.H. Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 17 (1997) 92-99
20. Kesner R.P., and Dakis M. Intrahippocampal injections of phencyclidine but not naloxone disrupt acquisition of a spatial continuous recognition memory task. Pharmacology, Biochemistry, and Behavior 56 (1997) 97-101
21. Le Pen G., Gaudet L., Mortas P., Mory R., and Moreau J.L. Deficits in reward sensitivity in a neurodevelopmental rat model of schizophrenia. Psychopharmacology 161 (2002) 434-441
22. Lee P.R., Brady D.L., Shapiro R.A., Dorsa D.M., and Koenig J.I. Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 30 (2005) 1883-1894
23. Lydall E.S., Dwyer D.M., and Gilmour G. Angel dust and anhedonia. Journal of Psychopharmacology 23 (2009) A66
24. Palumbo M.L., Fosser N.S., Rios H., Zorrilla Zubilete M.A., Guelman L.R., Cremaschi G.A., and Genaro A.M. Loss of hippocampal neuronal nitric oxide synthase contributes to the stress-related deficit in learning and memory. Journal of Neurochemistry 102 (2007) 261-274
25. Papp M., Willner P., and Muscat R. An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress. Psychopharmacology 104 (1991) 255-259
26. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1998), Academic Press, USA
27. Przegalinski E., Moryl E., and Papp M. The effect of 5-HT1A receptor ligands in a chronic mild stress model of depression. Neuropharmacology 34 (1995) 1305-1310
28. Redmond A.M., Harkin A., Kelly J.P., and Leonard B.E. Effects of acute and chronic antidepressant administration on phencyclidine (PCP) induced locomotor hyperactivity. European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology 9 (1999) 165-170
29. Reich C.G., Taylor M.E., and McCarthy M.M. Differential effects of chronic unpredictable stress on hippocampal CB1 receptors in male and female rats. Behavioural Brain Research 203 (2009) 264-269
30. Robbins T.W., and Everitt B.J. Neurobehavioural mechanisms of reward and motivation. Current Opinion in Neurobiology 6 (1996) 228-236
31. Rodefer J.S., Murphy E.R., and Baxter M.G. PDE10A inhibition reverses subchronic PCP-induced deficits in attentional set-shifting in rats. The European Journal of Neuroscience 21 (2005) 1070-1076
32. Rodefer J.S., Nguyen T.N., Karlsson J.J., and Arnt J. Reversal of subchronic PCP-induced deficits in attentional set shifting in rats by sertindole and a 5-HT(6) receptor antagonist: comparison among antipsychotics. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 33 (2008) 2657-2666
33. Sams-Dodd F. (+) MK-801 and phencyclidine induced neurotoxicity do not cause enduring behaviours resembling the positive and negative symptoms of schizophrenia in the rat. Basic & Clinical Pharmacology & Toxicology 95 (2004) 241-246
34. Sams-Dodd F. Phencyclidine-induced stereotyped behaviour and social isolation in rats: a possible animal model of schizophrenia. Behavioural Pharmacology 7 (1996) 3-23
35. Snigdha S., and Neill J.C. Efficacy of antipsychotics to reverse phencyclidine-induced social interaction deficits in female rats-a preliminary investigation. Behavioural Brain Research 187 (2008) 489-494
36. Snigdha S., and Neill J.C. Improvement of phencyclidine-induced social behaviour deficits in rats: involvement of 5-HT1A receptors. Behavioural Brain Research 191 (2008) 26-31
37. Snigdha S., and Neill J.C. Improvement of phencyclidine-induced social behaviour deficits in rats: involvement of 5-HT1A receptors. Journal of Psychopharmacology (Oxford, England) (2008)
38. Spielewoy C., and Markou A. Withdrawal from chronic phencyclidine treatment induces long-lasting depression in brain reward function. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 28 (2003) 1106-1116
39. Turgeon S.M., and Hoge S.G. Prior exposure to phencyclidine decreases voluntary sucrose consumption and operant performance for food reward. Pharmacology, Biochemistry, and Behavior 76 (2003) 393-400
40. Turgeon S.M., and Hulick V.C. Differential effects of acute and subchronic clozapine and haloperidol on phencyclidine-induced decreases in voluntary sucrose consumption in rats. Pharmacology, Biochemistry, and Behavior 86 (2007) 524-530
41. Turgeon S.M., Lin T., and Subramanian M. Subchronic phencyclidine exposure potentiates the behavioral and c-Fos response to stressful stimuli in rats. Pharmacology, Biochemistry, and Behavior 88 (2007) 73-81
42. Turgeon S.M., and Roche J.K. The delayed effects of phencyclidine enhance amphetamine-induced behavior and striatal C-Fos expression in the rat. Neuroscience 91 (1999) 1265-1275
43. Willner P., Muscat R., and Papp M. Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neuroscience and Biobehavioral Reviews 16 (1992) 525-534
44. Willner P., Sampson D., Papp M., Phillips G., Muscat R., and Soubrie P. Animal models of anhedonia. In: Anonymous (Ed). Animal Models of Psychiatric Disorders (1991), Karger, Basel 71-99
45. Zhang Z.J., and Reynolds G.P. A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia. Schizophrenia Research 55 (2002) 1-10
46. Zurita A., Martijena I., Cuadra G., Brandao M.L., and Molina V. Early exposure to chronic variable stress facilitates the occurrence of anhedonia and enhanced emotional reactions to novel stressors: reversal by naltrexone pretreatment. Behavioural Brain Research 117 (2000) 163-171